A utoimmune thyroiditis is a chronic organ-specific autoimmune disease characterized by infiltration of the thyroid gland by mononuclear cells and destruction of thyroid follicles by infiltrating inflammatory cells (1) . NOD.H-2h4 mice, which express the thyroiditis susceptibility I-A k allele on the NOD background (2) , develop spontaneous autoimmune thyroiditis (SAT) 3 after administration of NaI in their drinking water (3) (4) (5) . Previous studies have demonstrated that both CD4 ϩ and CD8 ϩ T cells are required for the development of SAT in NOD.H-2h4 mice (3, 5) . All mice that develop SAT produce detectable antiMTg autoantibodies, and levels of both IgG1 and IgG2b anti-MTg autoantibodies generally correlate with the severity of thyroid lesions (3) . However, it is not known whether the anti-MTg autoantibodies and/or B cells that produce anti-MTg autoantibodies are required for development of SAT. B cells are important for the development of several spontaneous autoimmune diseases including diabetes in NOD mice (6 -8) , SLE in MRL/Mp-lpr/lpr mice (9, 10) and arthritis in K/BxN mice (11) . In addition, some experimentally induced autoimmune diseases, including experimental autoimmune thyroiditis, collageninduced arthritis and experimental allergic encephalomyelitis (EAE) either do not develop or develop suboptimally in B celldeficient mice (Refs. 12-16 and H.B.-M., unpublished results).
The purpose of these studies was to determine whether B cells and/or autoantibodies produced by B cells were required for the development of SAT in NOD.H-2h4 mice. The results indicate that development of SAT is severely compromised in B cell-deficient mice. B cells are apparently required some time during the first 4 -6 wk after birth, and their function cannot be replaced by antiMTg autoantibodies.
Materials and Methods

Mice
NOD.H-2h4 mice, derived by crossing NOD mice with B10.A(4R) mice, with repetitive backcrosses to NOD using progeny expressing the MHC haplotype of B10.A(4R), were provided by Dr. Linda Wicker (Merck, Rahway, NJ), and subsequently bred and maintained under specific pathogenfree conditions in the animal facilities at the University of Missouri (3) . B lymphocyte-deficient NOD.Ig null mice (6) were provided by Dr. David Serreze (The Jackson Laboratory, Bar Harbor, ME). NOD.Ig null males were crossed with NOD.H-2h4 females and the resulting F 1 mice were bred to produce F 2 mice. The F 2 progeny were selected for homozygosity at H-2K k and lack of expression of H-2K d and for expression of the B cell markers B220 and IgM (Ig ϩ ) or lack of expression of B220 and IgM (Ig null ) by flow cytometric analysis of PBLs. Homozygous Ig ϩ mice were then selected by PCR analysis of tail DNA using published PCR primer sequences (6) . The resultant homozygous Ig ϩ or Ig null H-2K mice, hereafter designated NOD.K ϩ and NOD.K null , were bred and maintained under specific pathogen-free conditions, and the offspring were used for the studies reported here. Mice were age-and sex-matched for each individual experiment; both male and female mice were used for these experiments. All mice received 0.05% NaI in their drinking water beginning at 7-8 wk of age (3) , or in the bone marrow reconstitution experiments, at 12 wk of age.
B cell depletion with anti-IgM
For some experiments, B cells were depleted from newborn mice using rabbit anti-mouse IgM (Southern Biotechnology Associates, Birmingham, AL or Jackson ImmunoResearch, West Grove, PA) as described previously (17) . Mice received anti-IgM s.c. within the first 24 h after birth and three times weekly thereafter (50 g/injection), either throughout the experiment (16 wk) or for 1-4 wk after birth as specified in the Tables. When mice  were 3 (Table V) . One week later (7 wk after irradiation and bone marrow reconstitution), all mice were given NaI water, and were assessed for SAT 12 wk later. The time the mice were on NaI water was increased to 12 wk because preliminary experiments indicated that development of SAT was suboptimal at 8 wk in NOD.K ϩ recipients of ϩ bone marrow, presumably due to immunosuppression from the irradiation.
Assessment of thyroiditis
Eight to 9 wk (or 12 wk in Table V) after mice began receiving NaI in their water, thyroids were collected, fixed in formalin, sectioned, and stained with hematoxylin and eosin as previously described (3, 18) . As shown previously (3), thyroid lesions reach maximal severity 7-9 wk after NOD.H-2h4 mice are given NaI in their drinking water beginning at 2 mo of age; the lesions are chronic and remain relatively unchanged in severity for at least the next 20 wk (our unpublished observations). The NOD.K ϩ mice described above developed SAT with similar severity and kinetics to the NOD.H-2h4 mice. Thyroids were scored for the extent of follicle destruction (SAT severity) using a scale of 1 ϩ to 4 ϩ as previously described (3). Briefly, 1 ϩ thyroiditis is defined as an infiltrate of at least 125 cells in one or several foci, 2 ϩ represents 10 -20 foci of cellular infiltration, each the size of several follicles and involving up to 1/4 of the gland, 3
ϩ indicates that 1/4 to 1/2 of the gland is destroyed by infiltrating inflammatory cells, and 4 ϩ indicates that greater than 1/2 of the gland is destroyed. Qualitatively, the thyroid inflammatory cell infiltrate was typical of that seen in conventional lymphocytic experimental autoimmune thyroiditis, consisting primarily of lymphocytes and other mononuclear cells with occasional polymorphonuclear and plasma cells (3, 18) . Most thyroids also had some proliferation and enlargement of thyroid follicular cells. Follicular cell enlargement was evident even in many thyroids with insufficient inflammatory cell infiltration to receive a severity score of 1 ϩ , and was probably a consequence of the increased dietary iodine. All slides were coded before being scored by two individuals, one of whom had no knowledge of the experimental protocol.
Autoantibody determination
MTg-specific autoantibodies were assessed by ELISA using serum from individual mice as previously described (3, 19) . Alkaline phosphatase-conjugated secondary Abs specific for total mouse IgG or for mouse IgG1 and IgG2B were used at previously determined optimal dilutions (1:6000 or 1:8000), which gave an OD Ͻ0.05 with 1:50 diluted normal mouse serum on MTg-coated plates or with a 1:50 dilution of each test serum on plates coated with an irrelevant protein (OVA). Plates coated either with highly purified MTg or with less purified MTg preparations always gave identical results in this assay, suggesting that the IgG1 and IgG2b autoantibodies are directed against thyroglobulin, and not against another thyroid protein (3).
Flow cytometry
Spleen cells or PBL from experimental mice were analyzed for cell surface expression of B220, IgM, CD4, and CD8 by flow cytometry (FACSvantage; Becton Dickinson, San Jose, CA) as previously described (17 
Statistical analysis
A two-tailed Student's t test was used to determine the significance of differences in SAT severity between different groups. The p values are given in the footnotes in the tables.
Results
B cell-depleted mice develop minimal SAT
To determine whether B cells were required for development of SAT, NOD.H-2h4 mice were given anti-IgM beginning at birth and continuing through the entire 16 wk of the experiment as described in Materials and Methods. As shown in Table I , lines 1 and 2, 6 of 11 anti-IgM treated mice did not develop SAT, and the other 5 mice had mild (1 ϩ ) thyroiditis. Most of the thyroids of B cell-deficient mice with 1 ϩ severity scores had only one to two foci of inflammatory cells, the minimal criteria for receiving a 1 ϩ score (see Materials and Methods). In contrast, all 10 age-matched saline-injected control mice developed SAT, with 9 of 10 mice having a severity score of 2 ϩ -4
ϩ . All control mice had anti-MTg IgG1 and IgG2b autoantibodies, while anti-MTg autoantibodies were not significantly above background in sera of anti-IgM treated mice. Similar results were observed for mice genetically lacking B cells due to deletion of the Ig gene (Table I, 
B cells are required early in life before the development of SAT
To begin to define the function of B cells in SAT, it was of interest to determine whether B cell reconstitution at 6 -8 wk of age (before mice begin NaI water, and several weeks before thyroid lesions develop in B cell-intact mice; Ref.
3) would enable NOD.H2h4 mice to develop SAT. Adult NOD.K null mice could not be reconstituted with B cells from NOD.K ϩ mice (Table III, lines 6  and 7 , and data not shown), presumably because the transferred B cells were rejected by CD8 ϩ T cells (20) or inhibited by CD4 ϩ T cells (21) of the B cell-deficient mice. Therefore, the approach we used to reconstitute B cell-depleted mice with B cells was to stop the anti-IgM treatment at various times (1-3 wk) after birth and allow peripheral B cells (B220 and IgM ϩ cells) to gradually repopulate the mice. Although there was some variation in the rate of B cell reconstitution with different lots of anti-IgM, B cell percentages in peripheral blood usually returned to near normal levels (as determined by flow cytometry) 2-3 wk after stopping the antiIgM treatment. In the first experiment (Table II , lines 1-3), mice were treated with anti-IgM for the first 3 wk after birth. When mice were 6 wk old (2 wk before starting NaI water and 4 -5 wk before detectable thyroid lesions would develop in B cell-intact mice; Ref.
3), percentages of B220 ϩ (Table II, ϩ cells (not shown) in peripheral blood were similar to those of controls (line 1). However, mice treated with anti-IgM for only 3 wk after birth (line 3) had an incidence and severity of SAT comparable to mice in which B cell depletion was maintained throughout the experiment (line 2). In a second experiment, mice that received anti-IgM for only 1 wk (Table II , line 5) had normal percentages of peripheral B cells when tested at 6 wk of age, whereas mice given anti-IgM for 3 wk still had slightly lower percentages of peripheral B220 ϩ cells at 6 wk (line 6). Mice given anti-IgM for only 1 wk were as resistant to SAT as mice treated with anti-IgM for 3 wk (line 6) or, in other experiments, through the entire 16 wk of the experiment. These results suggest that B cells are required sometime during the first 4 -6 wk after birth for optimal development of SAT in adults, and the presence of normal numbers of B cells at 6 wk of age is not sufficient to promote development of SAT. Another possible interpretation of these results is that SAT development could simply be delayed in mice given anti-IgM for only 1-3 wk after birth. To address this possibility, half of the controls and half of the mice treated with anti-IgM for 3 wk in the second experiment in Table II were maintained on NaI water an additional 8 wk. As shown in Table II , lines 7 and 8, SAT severity scores in both groups assessed at 24 wk were not significantly different from those of each respective group at 16 wk (lines 4 and , and from a NOD.H-2h4 mouse treated for the first 3 wk after birth with anti-IgM (C and F). Spleens were obtained from mice at 16 wk of age; the mice received 0.05% NaI in their drinking water beginning at 8 wk of age; at 6 wk of age, mice treated with anti-IgM for 3 wk (C and F) had normal numbers of B220 ϩ cells in peripheral blood (Table II) . Staining of cells is described in Materials and Methods. Results are representative of all experiments of this type. a Male NOD.H-2h4 mice were given 50 g anti-IgM three times per week beginning at birth for the indicated number of weeks. At 8 wk, anti-IgM-treated and age-and sex-matched controls received 0.05% NaI in the drinking water. Thyroids of mice in lines 1-3 (Expt. 1) and lines 4 -6 (Expt. 2) were removed 8 wk after starting NaI water (mice were 16 wk of age). Mice in lines 7 and 8 were also in Expt. 2, were from the same litters, and were treated identically to the mice in lines 4 -6. These mice were maintained on NaI water for an additional 8 wk (i.e., thyroids were removed when the mice were 24 wk of age). 
Anti-MTg autoantibody production does not replace the requirement for B cells in SAT
Mice in which B cell depletion was maintained through 16 wk did not produce detectable anti-MTg autoantibodies (Table I and Table  II, line 2) . However, when anti-IgM treatment was stopped after 1-3 wk, most mice produced detectable anti-MTg autoantibodies, even though many of them did not develop thyroid lesions. Although the results shown in the Tables represent the mean ELISA results of the group, the mice having SAT severity scores of 1 ϩ did not contribute all the autoantibody to the group mean. In all these experiments, anti-IgM treated mice with 1 ϩ SAT severity scores had autoantibody responses that were indistinguishable from those of mice in the same group that had scores of 0 (data not shown). Anti-MTg autoantibodies were always much lower in the 1-3 wk B cell-depleted mice compared with controls, possibly because their B cells did not develop for several weeks after birth and, therefore, became activated later. When such mice were maintained on NaI water through 24 wk (Table II, (Table  II, line 7) , and IgG1 responses were higher than at 16 wk. Because these mice developed minimal or no SAT, the decreased autoantibody levels probably do not explain their relative resistance to SAT. In other experiments, mice depleted of B cells for 4 wk after birth were given serum containing anti-MTg autoantibodies from NOD.H-2h4 mice with SAT. Ab injections were begun at 11 wk (3 wk after the mice began NaI water, when autoantibodies first become detectable in controls; Ref.
3) and were continued weekly through 16 wk (Table III, lines 1-3) . Although IgG1 autoantibodies in mice receiving passive anti-MTg were lower than in controls, anti-MTg IgG2b levels were comparable to those of controls. However, mice given passive anti-MTg did not develop SAT, suggesting that a lack of circulating anti-MTg autoantibody may not be the critical factor responsible for the relative resistance of B cell-depleted mice to SAT. In another experiment, B cell-deficient NOD.K null mice were given B cells from NOD.K ϩ mice at 8 and 10 wk of age, and weekly injections of serum from MTgimmunized CBA/J mice containing high amounts of anti-MTg (Table III , lines 4 -7). As noted above, B cell reconstitution in adult NOD.K null mice was not effective (20, 21) , and the mice did not develop SAT (line 6). Mice receiving passive anti-MTg autoantibodies had higher levels of anti-MTg than controls, but they did not develop SAT (line 7). These results suggest the sole requirement for B cells is probably not to produce anti-MTg autoantibodies, although we cannot exclude the possibility that the transferred Ab differs in some important way, or does not gain access to the thyroid in the same way, as anti-MTg autoantibodies that develop spontaneously. In the experiment shown in Table IV , adult NOD.K null mice could be stably repopulated with B cells from NOD.K ϩ mice when they were irradiated (500 rad) before B cell transfer (line 3 vs line 4). Although many of these mice had fewer splenic B cells than control ϩ mice, the B cells were functional because the B cell-repopulated mice spontaneously produced as much anti-MTg IgG1 and IgG2b autoantibody as control ϩ mice (Table IV , line 4 vs lines 1 and 2). However, even though anti-MTg autoantibodies developed spontaneously and reached levels comparable to those of NOD.K ϩ mice, B cell-repopulated irradiated NOD.K null mice did not develop SAT. In contrast, 9 of 10 irradiated and nonirradiated NOD.K ϩ mice developed SAT (i.e., 500 rad irradiation did not inhibit development of SAT in ϩ mice). As shown above, unirradiated NOD.K null mice could not be reconstituted with B cells, and they did not develop SAT or produce anti-MTg autoantibodies (Table IV, line 3). These results indicate that mice given B cells as adults can spontaneously produce normal levels of circulating anti-MTg autoantibodies, but this does not enable them to develop SAT.
T cells from NOD.K null mice can induce SAT if they develop from precursors in the presence of B cells
The results presented above indicate that B cells are required during the first 4 -6 wk of life for optimal development of SAT, and this is probably not due solely to a requirement for circulating anti-MTg autoantibodies. If the inability of B cell-deficient mice to develop SAT is due to a lack of B cells during a critical time in the first 4 -6 wk after birth, NOD.K null mice should develop SAT if they are given B cells within 1-2 wk after birth. However, we were unable to achieve stable reconstitution of peripheral B cells when NOD.K null mice were given adult B cells at 1 or 2 wk of age (not shown). This is presumably due to the inhibitory effects of NOD.K null T cells on transferred B cells mentioned above (20, 21) . However, Igh null mice can be stably reconstituted with B cells when their T cells mature from immature bone marrow precursors in the presence of B cells (20) . This provided an alternative means to determine whether B cell-deficient NOD.K null mice could develop SAT if B cells were available when their T cells were maturing. To address this question, lethally irradiated mice were repopulated with bone marrow from either NOD.K ϩ or Table III . Passive transfer of anti-MTg autoantibody has no effect on the development of SAT 
Discussion
These results demonstrate that B cells are required for optimal development of SAT in NOD.H-2h4 mice. Because anti-MTg IgG1 and IgG2b autoantibody levels correlate with SAT severity in this model (3), it is probably not surprising that depletion of B cells largely prevented development of thyroid lesions. One explanation for the requirement for B cells for optimal development of SAT is that anti-MTg or other autoantibodies produced by B cells could play a role in destruction of the thyroid gland. Autoantibodies have direct pathogenic effects in several autoimmune disease models (11, 22, 23) , and there can also be synergism between T cells and B cells or autoantibodies (11, 14, 16, 23) . However, autoantibody production is probably not the only function of B cells in SAT because B cells were required before detectable autoantibodies were produced (Table II) , and passive transfer of anti-MTg or reconstitution of adult mice with B cells that spontaneously produced anti-MTg autoantibodies did not enable B celldeficient mice to develop SAT (Tables III and IV) . Although passively transferred autoantibodies may not be comparable to naturally produced autoantibodies with respect to concentration, time of development, access to the thyroid, or epitope specificity, irradiated adult NOD.K null reconstituted with B cells spontaneously produced as much anti-MTg as controls and did not develop SAT (Table IV) . Although our results do not exclude a secondary role for autoantibodies, they do suggest B cells have another important function(s) in SAT. a Female NOD.K ϩ or null mice were given 0.05% NaI in the drinking water beginning at 9 wk of age. Mice in lines 2 and 4 were irradiated (500 rad) and mice in lines 3 and 4 received 3 ϫ 10 7 B cells from adult NOD.K ϩ mice on the same day. b The number of mice with various degrees of severity of SAT 8 weeks after beginning NaI water. The p values are Ͻ0.003 (line 2 vs lines 3 or 4) . c Anti-MTg IgG1 and IgG2b expressed as OD 410 Ϯ SEM. d The percentage of B220 ϩ or CD4 ϩ cells in the spleen at the time thyroids were removed. The fact that B cells had to be present during the first few-wk after birth or when T cells were developing from bone marrow precursors (Tables II-V) places some constraints on the potential mechanisms by which B cells could function in SAT. Previous studies have shown that CD4 ϩ T cells from B cell-deficient mice can be activated by some foreign proteins or peptides (16, 17, 20, 24 -26) , but not others (17, 20, 24, (27) (28) (29) (30) . The nature of the Ag, the activation state of the T cells, and the T cell function (e.g. proliferation, help to B cells) being assessed can all influence whether T cell activation occurs in B cell-deficient mice (16, 17, 20, 24, 26, 31) . Dendritic cells are usually the most efficient APC for the initial sensitization of naive T cells, and B cells may function to amplify or sustain T cell responses initiated by other APC (9, 23, 32, 33, 35) . In some previous studies, T cells from B celldeficient mice could be activated when adult mice were reconstituted with B cells at the time of T cell priming (27) (28) (29) (30) (31) , suggesting that B cells were necessary for initial T cell activation.
Table V. T cells from B cell-deficient NOD.K mice induce SAT if they develop from bone marrow precursors in the presence of B cells
A role for B cells in activation of autoreactive T cells has been demonstrated in some autoimmune disease models. For example, autoreactive T cells were not activated spontaneously in SLEprone B cell-deficient mice (9, 10) , and T cells from B cell-deficient NOD mice could not be sensitized to the glutamate decarboxylase (GAD) autoantigen (20, 34) . Because B cell-deficient mice also did not develop autoimmune disease, these studies suggested B cells might function as APC for the activation or diversification of autoreactive T cells (20, 23, 34, 35) . However, in a model of EAE induced by myelin oligodendrocyte glycoprotein (MOG), B cell-deficient mice did not develop EAE, but their T cells were apparently activated because they produced similar amounts of Th1 cytokines upon restimulation by the major encephalitogenic epitope (MOG 35-55) as did T cells from similarly immunized B cell-intact mice, which did develop EAE (16) . Another study showed that islet-reactive T cells were apparently activated and could migrate to the pancreas in B cell-deficient NOD mice, but the inflammatory response was mild, and diabetes did not develop (8) . These two studies suggested autoreactive T cells could be activated in the absence of B cells, but the T cells were not pathogenic. Falcone et al. (34) showed that T cells from adult B cell-deficient NOD mice spontaneously proliferated to GAD when B cells were added in vitro, suggesting that initial sensitization to GAD did not require B cells, but B cells were required as APC for amplification of the response. However, NOD B cells were required for initial sensitization to GAD after immunization with GAD in adjuvant (20) . None of these studies have determined when B cells were required for development of autoimmune disease. One study showed that activated T cells could transfer diabetes to B cell-deficient mice (36) , suggesting B cells were not required as APC for reactivation of T cells in the target organ or for mediating damage to the pancreas. Consistent with the results reported here (Table V) , T cells from B cell-deficient mice could induce diabetes if they developed from bone marrow precursors in the presence of B cells (20) .
Our attempts to determine whether peripheral MTg-reactive T cells were spontaneously activated in B cell-deficient mice were inconclusive, possibly because MTg is a large protein with multiple potential T cell epitopes, only some of which are pathogenic and/or may require B cells for activation (37) . If B cells function primarily as APC for activation of pathogenic autoreactive T cells in SAT, it is surprising the T cells were apparently not activated when B cells became available in mice 6 -8 wk of age (Tables II  and IV) . In the experiment shown in Table IV , B cells given to adult mice spontaneously produced anti-MTg autoantibodies comparable to NOD.K ϩ mice, suggesting that failure to spontaneously produce sufficient anti-MTg autoantibody does not explain their inability to develop SAT. Although we cannot completely exclude the possibility that B cell-deficient mice might have eventually developed SAT in our experiments, a period of 10 -11 wk after B cell reconstitution until assessment of SAT (Table II) should have been sufficient for T and B cells to migrate to the thyroid (2-5). In addition, one group of mice treated with anti-IgM for 3 wk after birth was maintained on NaI water for 16 wk instead of the usual 8 wk. These mice had autoantibody responses only slightly lower than B cell-intact mice, but they developed minimal or no SAT (Table II, line 8) . Although T cells from B cell-deficient NOD.K mice could not be activated to induce SAT when B cells were made available in adults, their T cells did induce SAT when they matured from bone marrow precursors in the presence of B cells (Table V) . These results indicate that T cells from B celldeficient NOD.K mice can be effectively activated to become effector cells for SAT if B cells are present during their maturation.
The fact that mice reconstituted with B cells as adults do not develop SAT, while those given B cells during the maturation of T cells from bone marrow precursors do develop SAT, suggests the initial activation of autoreactive T cells may be an early event. If T cell activation does not occur before mice are about 6 wk of age, the T cells apparently are unable to respond even if B cells become available in adults. It is also possible, although probably less likely, that the T cell epitope that initiates SAT is only present in neonatal mice. Although tolerance to self Ags expressed in the thymus develops during ontogeny, T cells specific for self Ags not expressed in the thymus or expressed at levels that escape negative selection are present in the periphery at birth (38 -44) . These nontolerant, potentially autoreactive T cells can become activated in certain strains of mice, resulting in spontaneous autoimmune disease (44, 45) ; activation of such cells can be facilitated by B cells (9, 10, 23, 35, 46) . Garza et al. (43, 44) showed that T cells able to respond to a physiologically expressed self Ag ZP3, expressed by the ovary are present in neonatal mice. Tolerance to ZP3 develops in the first week of life in female mice that express the Ag, but not in males that do not express ZP3 (44) . Our results would be compatible with such a mechanism if B cells either produce or are required for presentation of the epitope that initiates SAT in NOD.H-2h4 mice. B cells that become available in adults may be unable to activate autoreactive T cells because the T cells able to respond to the epitope that initiates T cell activation in this model were eliminated or inactivated in the absence of B cells in neonates. Experiments to test this hypothesis are in progress.
Because thyroids of mice with SAT have many infiltrating B cells found in clusters with CD4 ϩ T cells, (54) , B cells could also be required after T cells have migrated to the thyroid. Although B cells clearly have an early role in SAT (Tables II-IV) , B cells could also produce autoantibodies or present Ag to T cells to amplify or sustain the inflammatory response in the target organ. Ags presented to T cells in the target organ could be proteins released during initial damage to the thyroid or proteins that become iodinated when mice receive NaI in their water. These Ags may differ from the Ag that initiates autoreactive T cell activation, because B cells were initially required well before cells migrated to the thyroid, and several weeks before acceleration of SAT by NaI water (Tables II and IV ., unpublished observations) . These results may suggest B cells given to adult mice are not inherently unable to migrate to the thyroid, although this is difficult to prove, as the numbers of infiltrating cells (T or B) in mice with such mild lesions are very low.
To our knowledge, this is the first study to demonstrate an early role for B cells for development of a spontaneous autoimmune disease. A requirement for B cells or B cell Ig early after birth for activation of particular subsets of T cells has been demonstrated previously (17, (47) (48) (49) (50) . B cells can also present Ig determinants to T cells (51) , and natural IgM has been shown to play a role in maturation of the immune response (52) . We have previously shown that normal mouse Ig could substitute for B cells in T cell activation (17) . Normal mouse Ig given to anti-IgM treated or NOD.K null mice using the regimen that was successful in our earlier study (17) had no effect on the ability of B cell-deficient mice to develop SAT (data not shown). This suggests that B cells probably do not simply provide Ig that could promote T cell activation or selection of the T cell repertoire by various mechanisms (47) (48) (49) (50) (51) (52) , unless the Ig component is an autoantibody (53) and/or is unique to NOD.H-2h4 mice. To address some of these questions, we are generating NOD.K null mice that express transgenic surface Ig ϩ B cells that do not secrete Ig (10) to provide a model in which B cells will be present at birth, but autoantibody will not be produced.
